173 related articles for article (PubMed ID: 17725851)
21. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria.
Lamhonwah AM; Tein I
Biochem Biophys Res Commun; 2006 Jul; 345(4):1315-25. PubMed ID: 16729965
[TBL] [Abstract][Full Text] [Related]
22. Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells.
Elimrani I; Lahjouji K; Seidman E; Roy MJ; Mitchell GA; Qureshi I
Am J Physiol Gastrointest Liver Physiol; 2003 May; 284(5):G863-71. PubMed ID: 12684216
[TBL] [Abstract][Full Text] [Related]
23. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Ohashi R; Tamai I; Yabuuchi H; Nezu JI; Oku A; Sai Y; Shimane M; Tsuji A
J Pharmacol Exp Ther; 1999 Nov; 291(2):778-84. PubMed ID: 10525100
[TBL] [Abstract][Full Text] [Related]
24. Expression and adaptive regulation of amino acid transport system A in a placental cell line under amino acid restriction.
Jones HN; Ashworth CJ; Page KR; McArdle HJ
Reproduction; 2006 May; 131(5):951-60. PubMed ID: 16672359
[TBL] [Abstract][Full Text] [Related]
25. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
[TBL] [Abstract][Full Text] [Related]
26. Expression, localization, and function of the carnitine transporter octn2 (slc22a5) in human placenta.
Grube M; Meyer Zu Schwabedissen H; Draber K; Präger D; Möritz KU; Linnemann K; Fusch C; Jedlitschky G; Kroemer HK
Drug Metab Dispos; 2005 Jan; 33(1):31-7. PubMed ID: 15486076
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia blocks 11beta-hydroxysteroid dehydrogenase type 2 induction in human trophoblast cells during differentiation by a time-dependent mechanism that involves both translation and transcription.
Homan A; Guan H; Hardy DB; Gratton RJ; Yang K
Placenta; 2006 Aug; 27(8):832-40. PubMed ID: 16271275
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model.
Sayed-Ahmed MM; Al-Shabanah OA; Hafez MM; Aleisa AM; Al-Rejaie SS
Eur J Pharmacol; 2010 Aug; 640(1-3):143-9. PubMed ID: 20470772
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the relative antioxidant potency of L-ergothioneine and idebenone.
Dong KK; Damaghi N; Kibitel J; Canning MT; Smiles KA; Yarosh DB
J Cosmet Dermatol; 2007 Sep; 6(3):183-8. PubMed ID: 17760697
[TBL] [Abstract][Full Text] [Related]
30. Cloning and functional characterization of a novel up-regulator, cartregulin, of carnitine transporter, OCTN2.
Nagai K; Takikawa O; Kawakami N; Fukao M; Soma T; Oda A; Nishiya T; Hayashi M; Lu L; Nakano M; Kajita E; Fujita H; Miwa S
Arch Biochem Biophys; 2006 Aug; 452(1):29-37. PubMed ID: 16839516
[TBL] [Abstract][Full Text] [Related]
31. OCTN2 is associated with carnitine transport capacity of rat skeletal muscles.
Furuichi Y; Sugiura T; Kato Y; Shimada Y; Masuda K
Acta Physiol (Oxf); 2010 Sep; 200(1):57-64. PubMed ID: 20219053
[TBL] [Abstract][Full Text] [Related]
32. GFP-Human high-affinity carnitine transporter OCTN2 protein: subcellular localization and functional restoration of carnitine uptake in mutant cell lines with the carnitine transporter defect.
Lamhonwah AM; Tein I
Biochem Biophys Res Commun; 1999 Nov; 264(3):909-14. PubMed ID: 10544029
[TBL] [Abstract][Full Text] [Related]
33. Induction of zinc transporters by forskolin in human trophoblast BeWo cells.
Asano N; Kondoh M; Ebihara C; Fujii M; Nakanishi T; Utoguchi N; Enomoto S; Tanaka K; Watanabe Y
Reprod Toxicol; 2006 Apr; 21(3):285-91. PubMed ID: 16503475
[TBL] [Abstract][Full Text] [Related]
34. Wide tolerance to amino acids substitutions in the OCTN1 ergothioneine transporter.
Frigeni M; Iacobazzi F; Yin X; Longo N
Biochim Biophys Acta; 2016 Jun; 1860(6):1334-42. PubMed ID: 26994919
[TBL] [Abstract][Full Text] [Related]
35. Cationic polyrotaxanes effectively inhibit uptake via carnitine/organic cationic transporters without cytotoxicity.
Utsunomiya H; Katoono R; Yui N; Sugiura T; Kubo Y; Kato Y; Tsuji A
Macromol Biosci; 2008 Jul; 8(7):665-9. PubMed ID: 18366149
[TBL] [Abstract][Full Text] [Related]
36. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
[TBL] [Abstract][Full Text] [Related]
37. OCTN2-mediated carnitine uptake in a newly discovered human proximal tubule cell line (Caki-1).
Glube N; Closs E; Langguth P
Mol Pharm; 2007; 4(1):160-8. PubMed ID: 17274673
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological rescue of carnitine transport in primary carnitine deficiency.
Amat di San Filippo C; Pasquali M; Longo N
Hum Mutat; 2006 Jun; 27(6):513-23. PubMed ID: 16652335
[TBL] [Abstract][Full Text] [Related]
39. The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate.
Grigat S; Fork C; Bach M; Golz S; Geerts A; Schömig E; Gründemann D
Drug Metab Dispos; 2009 Feb; 37(2):330-7. PubMed ID: 18981167
[TBL] [Abstract][Full Text] [Related]
40. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.
Ciacci C; Peluso G; Iannoni E; Siniscalchi M; Iovino P; Rispo A; Tortora R; Bucci C; Zingone F; Margarucci S; Calvani M
Dig Liver Dis; 2007 Oct; 39(10):922-8. PubMed ID: 17693145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
